ADYNXX
Adynxx a biopharmaceutical company, develops pain management drugs. It offers AYX1, a drug candidate to prevent acute post-operative pain and its transition into chronic pain; and AYX therapeutic programs, including long-term relief treatments for mature chronic pain syndromes. The company was incorporated in 2007 and is based in San Francisco, California.
ADYNXX
Industry:
Biopharma Biotechnology Pharmaceutical
Founded:
2007-01-01
Address:
San Francisco, California, United States
Country:
United States
Website Url:
http://www.adynxx.com
Total Employee:
1+
Status:
Closed
Contact:
415-512-7740
Total Funding:
23.54 M USD
Technology used in webpage:
Domain Not Resolving Mobile Non Scaleable Content GoDaddy DNS GoDaddy
Current Advisors List
Current Employees Featured
Founder
Acquisitions List
| Date | Company | Article | Price |
|---|---|---|---|
| 2018-10-15 | Alliqua BioMedical | Alliqua BioMedical acquired by Adynxx | N/A |
Investors List
Domain Associates
Domain Associates investment in Series B - Adynxx
TPG Biotech
TPG Biotech investment in Series B - Adynxx
Domain Associates
Domain Associates investment in Venture Round - Adynxx
Official Site Inspections
http://www.adynxx.com Semrush global rank: 15.34 M Semrush visits lastest month: 9
- Host name: 172.67.157.107
- IP address: 172.67.157.107
- Location: United States
- Latitude: 37.751
- Longitude: -97.822
- Timezone: America/Chicago
More informations about "Adynxx"
Adynxx - Crunchbase Company Profile & Funding
Adynxx a biopharmaceutical company, develops pain management drugs. It offers AYX1, a drug candidate to prevent acute post-operative pain and its …See details»
Adynxx, Inc - LinkedIn
Adynxx, Inc | 134 followers on LinkedIn. Adynxx, located in San Francisco, is a clinical-stage biotechnology company developing a transformative technology platform addressing pain at its ...See details»
Adynxx, Inc. Company Profile | San Francisco, CA | Competitors ...
Find company research, competitor information, contact details & financial data for Adynxx, Inc. of San Francisco, CA. Get the latest business insights from Dun & Bradstreet.See details»
Adynxx, Inc. (ADYX) Company Profile & Facts - Yahoo Finance
See the company profile for Adynxx, Inc. (ADYX) including business summary, industry/sector information, number of employees, business summary, corporate governance, key executives …See details»
Adynxx Company Profile - Office Locations, Competitors, Revenue …
Oct 29, 2024 Adynxx is a biopharmaceutical company focused on bringing to market disease-modifying products for the treatment of pain and inflammation. It works to discover and …See details»
Adynxx (ADYX) Company Profile & Description - Stock Analysis
Adynxx, Inc., a clinical stage biopharmaceutical company, focuses on the development and marketing of transcription factor decoy technologies for the treatment of pain and inflammatory …See details»
Adynxx Completes Merger with Alliqua BioMedical, Adds
May 6, 2019 In connection with the merger, Alliqua has changed its name to Adynxx, Inc. The combined organization will commence trading on May 6, 2019 on the Nasdaq Capital Market …See details»
Adynxx, Inc. - VentureRadar
Adynxx's lead compound, AYX1, is an investigational drug designed to reduce acute post-surgical pain and prevent the transition to persistent or chronic pain with a single administration at the …See details»
www.adynxx.com
Www.adynxx.comSee details»
Adynxx 2025 Company Profile: Valuation, Funding
Adynxx General Information Description. Adynxx Inc is a United States-based clinical-stage biopharmaceutical company. It is focused on the development of a new class of therapeutics called transcription factor decoys and bringing to the …See details»
Adynxx - Contacts, Employees, Board Members, Advisors
Adynxx is a biopharmaceutical company that develops pain management drugs. New. Resources. Advanced Search. Start Free Trial . Talk With Sales ... Experience the new Crunchbase, …See details»
Adynxx - 2025 Company Profile, Funding & Competitors - Tracxn
Apr 6, 2025 Adynxx is a public company based in San Francisco (United States), founded in 2007 by Julien Mamet. It operates as a Developer of oligonucleotide technology for developing …See details»
Adynxx, Inc. - Drug pipelines, Patents, Clinical trials - Synapse
Explore Adynxx, Inc. with its drug pipeline, therapeutic area, technology platform, 15 clinical trials, 7 news, and 6 literature, Drug:Brivoligide, AYX-3, Influenza Virus Vaccine (HepaLife), …See details»
Adynxx - Overview, News & Similar companies | ZoomInfo.com
Oct 2, 2019 Adynxx Adds Gregory J. Flesher to Board of Directors, Completes Up-listing to OTCQB Market SAN FRANCISCO, July 22, 2019 (GLOBE NEWSWIRE) -- Adynxx, Inc. …See details»
Adynxx - The Pharmaletter
Adynxx In October 2018, the San Francisco-based company announced a merger , subject to closing, with Alliqua BioMedical under which the stockholders of Adynxx would become the …See details»
Company Adynxx, Inc. - MarketScreener.com
Adynxx, Inc. is a clinical-stage biopharmaceutical company. The Company is focused on the development of a new class of therapeutics called transcription factor decoys and bringing to …See details»
Adynxx Stock Data, Filings, Earnings, News & Transcripts
Adynxx, Inc. is a clinical stage biopharmaceutical company. It engages in the manufacture, development, and sale of novel, disease-modifying products for the treatment of pain and …See details»
Adynxx (ADYX) Stock Price & Overview - Stock Analysis
5 days ago Adynxx, Inc., a clinical stage biopharmaceutical company, focuses on the development and marketing of transcription factor decoy technologies for the treatment of pain …See details»
Adynxx merges with Alliqua, snagging Nasdaq listing ahead of …
Oct 12, 2018 Adynxx has backed away from plans to move the drug straight into phase 3 on the strength of the midphase data. But, with its current development plan centering on two …See details»